LoginSignup
SOP

Sophia Genetics

Stock
Stock
ISIN: CH1125843347
Ticker: SOPH
CH1125843347
SOPH

Price

Price

CHART BY

Frequently asked questions

What is Sophia Genetics's market capitalization?

The market capitalization of Sophia Genetics is $213.12M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Sophia Genetics?

Sophia Genetics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.087. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Sophia Genetics's stock?

Currently, 6 analysts cover Sophia Genetics's stock, with a consensus target price of $7.00. Analyst ratings provide insights into the stock's expected performance.

What is Sophia Genetics's revenue over the trailing twelve months?

Over the trailing twelve months, Sophia Genetics reported a revenue of $64.49M.

What is the EBITDA for Sophia Genetics?

Sophia Genetics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$60.00M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Sophia Genetics?

Sophia Genetics has a free cash flow of -$44.03M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Sophia Genetics have, and what sector and industry does it belong to?

Sophia Genetics employs approximately 449 people. It operates in the Health Care sector, specifically within the Packaged Software industry.

What is the free float of Sophia Genetics's shares?

The free float of Sophia Genetics is 51.15M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$213.12M
EPS (TTM) 
-$1.087
Free Float 
51.15M
Revenue (TTM) 
$64.49M
EBITDA (TTM) 
-$60.00M
Free Cashflow (TTM) 
-$44.03M

Pricing

1D span
$3.054$3.28
52W span
$2.70$7.37

Analyst Ratings

The price target is $7.00 and the stock is covered by 6 analysts.

Buy

5

Hold

1

Sell

0

Information

SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Employees
449
Industries
Packaged Software
Sector
Health Care

Identifier

ISIN
CH1125843347
Primary Ticker
SOPH

Knockouts

Join the conversation
Sign upLogin